Page tree
Skip to end of metadata
Go to start of metadata


Date

20220401

Document Version

1.0

Release Status

PRODUCTION

© 2023 International Health Terminology Standards Development Organisation.  All rights reserved.  SNOMED CT® was originally created by the College of American Pathologists.

This document forms part of the SNOMED CT® New Zealand Extension release distributed by International Health Terminology Standards Development Organisation, trading as SNOMED International, and is subject to the SNOMED CT® Affiliate License, details of which may be found at https://www.snomed.org/snomed-ct/get-snomed

No part of this document may be reproduced or transmitted in any form or by any means, or stored in any kind of retrieval system, except by an Affiliate of SNOMED International in accordance with the SNOMED CT® Affiliate License. Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International.

Any copy of this document that is not obtained directly from SNOMED International [or a Member of SNOMED International] is not controlled by SNOMED International, and may have been modified and may be out of date. Any recipient of this document who has received it by other means is encouraged to obtain a copy directly from SNOMED International [or a Member of SNOMED International. Details of the Members of SNOMED International may be found at http://www.snomed.org/members/].








Page At A Glance

Introduction

The Ministry of Health works with health and disability agencies and their industry partners to develop SNOMED CT® reference sets, maps, language reference sets and other content for digital health solutions in Aotearoa New Zealand.

The SNOMED CT New Zealand Extension packages these components for release every April and October, to be used with the latest designated SNOMED CT International Edition release.

The same content can be viewed online using the SNOMED CT browser and accessed via our standard SNOMED CT terminology service

We welcome your feedback and participation. For more information about SNOMED CT implementation in New Zealand, see our website or join our standards channel at forum.hinz.org.nz.

Background

This document provides a summarized description of the content changes included in the April 2022 production release of the SNOMED NZ Extension package.

It will also include technical notes detailing any known issues which have been identified. These are content or technical issues where the root cause is understood, and the fix has been discussed and agreed, but has yet to be implemented.

This SNOMED NZ Extension package is dependent upon, and should therefore be consumed in conjunction with the SNOMED CT January 2022 International Edition release.

Content development activity

Summary

Content from the SNOMED CT January 2022 International Edition release has been incremented, using additional components for use in New Zealand. 

The April 2022 release includes updates to the previously released content in the SNOMED CT NZ Extension release and introduces some new content.

New and updated content

Concept statistics

The SNOMED NZ National Release Centre promoted 5 new concepts into the SNOMED CT January 2022 International Edition release.

Table 1. New concepts in the SNOMED International January 2022 release by hierarchy

Total number of concepts5
Qualifier value (qualifier value)5

 Refer to Appendix 1, Table 1.1 to view the 5 new concepts.


There are 213 new concepts in this release.

Table 2. New concepts in the SNOMED NZ Extension April 2022 release by hierarchy

Total number of concepts

213

Clinical finding (finding)

24

Procedure (procedure)

154

Qualifier value (qualifier value)

2

Situation with explicit context (situation)

30

SNOMED CT Model Component (metadata)

2

Social context (social concept)1

Refer to Appendix 1, Table 2.1 to view the 213 new concepts.

Description statistics 

The SNOMED NZ NRC promoted 1 new descriptions to the SNOMED International Edition January 2022 release.

Table 3. New descriptions in the SNOMED International January 2022 release 

SNOMED CT Concept ID (SCTID)

SNOMED CT Fully Specified Name (FSN)

New description

2451000175103

Perinatology service (qualifier value)

Maternal fetal medicine service


There are 56 new descriptions in this release.

Table 4 New descriptions in the SNOMED NZ Extension April 2022 release

SNOMED CT Concept ID (SCTID)SNOMED CT Fully Specified Name (FSN)New description
171417004

Pre-school child health examination (procedure)

Before school check

472825005

Fetal chromosomal abnormality screening (procedure)

Fetal anomaly screening

445903002

Insertion of cardiac monitoring implant using fluoroscopic guidance (procedure)

Insertion of a pacemaker reveal monitor using fluoroscopic guidance

1163003002

Colorectal cancer screening service (qualifier value)

NZ bowel screening programme

14926007

pM1 category (finding)

pM1

443841006

pM1a category (finding)

pM1c

443840007

pM1b category (finding)

pM1a

443839005

pM1c category (finding)

pM1c

21917009

pN0 category (finding)

pN0

443335006

pN0(i-) category (finding)

pN0(i-)

443486002

pN0(i+) category (finding)

pN0(i+)

443963003

pN0(mol-) category (finding)

pN0(mol-)

443875007

pN0(mol+) category (finding)

pN0(mol+)

45552005

pN1 category (finding)

pN1

443716008

pN1a category (finding)

pN1a

443599002

pN1b category (finding)

pN1b

443743003

pN1c category (finding)

pN1c

443824009

pN1mi category (finding)

pN1mi

15076001

pN2 category (finding)

pN2

443867001

pN2a category (finding)

pN2a

443452006

pN2b category (finding)

pN2b

443893008

pN2c category (finding)

pN2c

49182004

pN3 category (finding)

pN3

443866005

pN3a category (finding)

pN3a

443962008

pN3b category (finding)

pN3b

443823003

pN3c category (finding)

pN3c

80663004

pN4 category (finding)

pN4

54452005

pNX category (finding)

pNX

39880006

pT0 category (finding)

pT0

53786006

pT1 category (finding)

pT1

443357004

pT1a category (finding)

pT1a

444432000

pT1a1 category (finding)

pT1a1

444439009

pT1a2 category (finding)

pT1a2

443506002

pT1b category (finding)

pT1b

444417007

pT1b1 category (finding)

pT1b1

444440006

pT1b2 category (finding)

pT1b2

443642002

pT1c category (finding)

pT1c

443600004

pT1mic category (finding)

pT1mi

80898003

pT2 category (finding)

pT2

443812002

pT2a category (finding)

pT2a

443896000

pT2b category (finding)

pT2b

443956003

pT2c category (finding)

pT2c

90402004

pT3 category (finding)

pT3

443606005

pT3a category (finding)

pT3a

443815000

pT3a,b category (finding)

pT3a,b

443817008

pT3b category (finding)

pT3b

443674009

pT3c category (finding)

pT3c

443784000

pT3c,d category (finding)

pT3c,d

443479005

pT3d category (finding)

pT3d

6123003

pT4 category (finding)

pT4

443604008

pT4a category (finding)

pT4a

443736009

pT4b category (finding)

pT4b

443721006

pT4c category (finding)

pT4c

443505003

pT4d category (finding)

pT4d

84921008

pTis category (finding)

pTis

43189003

pTX category (finding)

pTX

Reference sets

There are 57 reference sets in the April 2022 release.

For more information about New Zealand reference sets, please visit our website.

The New Zealand reference set list is available in Appendix 1, table 3.1.

Language reference sets

Language reference sets are created to define preferred terms and synonyms associated with each concept. There are three language reference sets in the April 2022 release.

Language Reference Set Name

SNOMED CT Concept ID (SCTID)

Members

Maori [International Organization for Standardization 639-1 code mi] language reference set (foundation metadata concept)

291000210106


 157

New Zealand English language reference set (foundation metadata concept)

271000210107


1155061

New Zealand English patient friendly terms language reference set (foundation metadata concept)

281000210109


157

Maps

Five maps between SNOMED CT and other code systems are contained in the April 2022 release.

Map Name

SNOMED CT Concept ID (SCTID)

Members

ACC translation table map (foundation metadata concept)

401000210101

12795

MSD translation table map (foundation metadata concept)

411000210104

58134

NZMT medicinal product to SNOMED CT map (foundation metadata concept)

311000210107

2125

READ v2 to SNOMED CT map (foundation metadata concept)

31000210106

88273

SNOMED CT to READ v2 map (foundation metadata concept)

41000210103

66966

Technical notes

Known Issues 

Known Issues are content or technical issues where the root cause is understood, and the resolution has been discussed and agreed but has yet to be implemented.  This can be due to a number of reasons, from lack of capacity within the current editing cycle, to the risk of impact to the stability of SNOMED CT if the fix were to be deployed at that stage in the Product lifecycle.  

The following known issues were identified, and agreed to be resolved in the next editing cycle:

Key Summary Description P
Loading...
Refresh

Notice of changes to the International Edition Release Schedule

As you may already know SNOMED International are transitioning to a monthly delivery schedule for the International Edition of SNOMED CT. The move towards more frequent releases of SNOMED CT will realize several benefits, including:

  • The potential to be able to get content changes into the terminology in a shorter time frame.
  • The fostering of better interoperability, as a result of entities being able to consume release content that is more aligned with other organizations.
  • The prevention of circular dependencies that occur in longer projects, due to the move towards smaller, more manageable authoring projects.
  • More automated validation services, as a result of the inherent removal of the Alpha/Beta stages in the Release cycle.

Whilst most users will continue unaffected (as they can simply continue to download the releases every 6 months as always), this transition will necessarily involve a few changes to process/packages:

  • Delta files have been removed from both International and Managed Service release packages, including the New Zealand Extension.  A Delta Generation service will be provided for those who need it. The Delta Generation Tool allows users to create their own Delta between two fixed release dates - you can find it here:
  • The ICD-O/ICD-10 Maps will continue to be published in each Monthly International Edition release package (in line with that month's content) for the foreseeable future, unless we experience issues with the new process in Production, and they need to be removed at a later date.

The first monthly Release of the SNOMED CT International Edition was published on the 28th February 2022 with the Delta files having been removed, and therefore they will be removed from the New Zealand Extension from the April 2022 Release onwards.

Please note - While the SNOMED CT International Edition is moving to monthly releases, the New Zealand Extension of SNOMED CT will remain on the current bi-annual release schedule of April and October for 2022.

Appendix 1

Table 1.1. New concepts in SNOMED CT International Edition January 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Semantic tag

1163003002

Colorectal cancer screening service (qualifier value)

Qualifier value

1163004008

Hyperbaric medicine service (qualifier value)

Qualifier value

1163002007

Electrocardiography service (qualifier value)

Qualifier value

1136421000168109

Sleep medicine service (qualifier value)

Qualifier value

1163054002

Gastroscopy service (qualifier value)

Qualifier value


Table 2.1. New concepts in the SNOMED NZ Extension April 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Semantic tag

81461000210103

Ring tight on digit of foot (disorder)

Disorder

81451000210101

Ring tight on digit of hand (disorder)

Disorder

91631000210108

Analgesics not given (finding)

Finding

101561000210107

Cesarean section assessment (finding)

Finding

91771000210102

Cesarean section category 1 - immediately life treatening to the woman or fetus (finding)

Finding

101531000210103

Cesarean section category 2 - woman or fetus compromised not immediately life treatening (finding)

Finding

101541000210106

Cesarean section category 3 - decision for earlier delivery made by health service (finding)

Finding

101551000210109

Cesarean section category 4 - decision for rescheduled delivery made by health service and woman (finding)

Finding

101481000210100

Fully breastfed (finding)

Finding

91571000210109

In transit birth (finding)

Finding

101601000210107

Infant artificially fed (finding)

Finding

91671000210105

Newborn hearing screening failure referred to specialist (finding)

Finding

91651000210102

Newborn hearing screening passed (finding)

Finding

91661000210104

Newborn hearing screening passed surveillance required (finding)

Finding

91641000210100

Newborn hearing screening status (finding)

Finding

101641000210105

Partially breastfed (finding)

Finding

91541000210104

Primary facility birth (finding)

Finding

91551000210101

Secondary facility birth (finding)

Finding

91601000210103

Stopped drinking alcohol before pregnancy (finding)

Finding

101491000210103

Stopped drinking alcohol during first trimester of pregnancy (finding)

Finding

91611000210101

Stopped drinking alcohol during pregnancy (finding)

Finding

101501000210108

Stopped drinking alcohol during second trimester of pregnancy (finding)

Finding

101511000210105

Stopped drinking alcohol during third trimester of pregnancy (finding)

Finding

91561000210103

Tertiary facility birth (finding)

Finding

121531000210107

New Zealand radiology procedures reference set (foundation metadata concept)

Foundation metadata concept

121521000210105

New Zealand severe acute respiratory syndrome coronavirus 2 symptoms reference set (foundation metadata concept)

Foundation metadata concept

81481000210106

Rural hospital medicine specialist (occupation)

Occupation

121541000210104

Aspiration and/or drainage of back region using computed tomography guidance (procedure)

Procedure

121551000210101

Aspiration and/or drainage of neck using computed tomography guidance (procedure)

Procedure

111521000210103

Combined first trimester maternal serum and nuchal translucency scan (procedure)

Procedure

131511000210102

Diagnostic radiography of temporomandibular joint and orthopantogram (procedure)

Procedure

101711000210104

Gateway assessment (procedure)

Procedure

101621000210104

Induction of labor by artificial rupture of membranes and using oxytocin (procedure)

Procedure

121511000210100

Non-invasive Prenatal Screening (procedure)

Procedure

101581000210104

Non-opioid analgesic therapy (procedure)

Procedure

111481000210103

Non-pharmacological pain management therapy (procedure)

Procedure

101661000210106

Opioid analgesic therapy (procedure)

Procedure

101721000210109

Referral for Gateway assessment (procedure)

Procedure

111531000210101

Second trimester maternal serum screening (procedure)

Procedure

91511000210100

X-ray of chest, cervical spine and pelvis (procedure)

Procedure

91581000210106

Pacific health service (qualifier value)

Qualifier value

91591000210108

Plunket service (qualifier value)

Qualifier value

58481000210105

Breast metastatic Abraxane-paclitaxel nanoparticle albumin bound and atexolizumab chemotherapy regimen (regime/therapy)

Regime/therapy

58601000210103

Breast metastatic carboplatin and gemcitabine chemotherapy regimen (regime/therapy)

Regime/therapy

57791000210102

Breast metastatic carboplatin chemotherapy regimen (regime/therapy)

Regime/therapy

58531000210107

Breast metastatic denosumab chemotherapy regimen (regime/therapy)

Regime/therapy

58641000210100

Breast metastatic doxorubicin every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

58611000210101

Breast metastatic doxorubicin weekly chemotherapy regimen (regime/therapy)

Regime/therapy

57781000210104

Breast metastatic epirubicin and cyclophosphamide chemotherapy regimen (regime/therapy)

Regime/therapy

58631000210108

Breast metastatic eribulin chemotherapy regimen (regime/therapy)

Regime/therapy

58491000210107

Breast metastatic everolimus and exemestane chemotherapy regimen (regime/therapy)

Regime/therapy

58541000210104

Breast metastatic fulvestrant chemotherapy regimen (regime/therapy)

Regime/therapy

58591000210108

Breast metastatic gemcitabine chemotherapy regimen (regime/therapy)

Regime/therapy

57801000210103

Breast metastatic goserelin every four weeks chemotherapy regimen (regime/therapy)

Regime/therapy

58561000210103

Breast metastatic goserelin every twelve weeks chemotherapy regimen (regime/therapy)

Regime/therapy

58511000210100

Breast metastatic Kadcyla- trastuzumab emtansine chemotherapy regimen (regime/therapy)

Regime/therapy

58521000210105

Breast metastatic mitomycin, mitoxantrone and methotrexate chemotherapy regimen (regime/therapy)

Regime/therapy

58581000210106

Breast metastatic paclitaxel weekly and trastuzumab every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

58501000210102

Breast metastatic paclitaxel weekly chemotherapy regimen (regime/therapy)

Regime/therapy

58621000210106

Breast metastatic paclitaxel weekly, pertuzmab and trastuzumab every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

57811000210101

Breast metastatic palbociclib chemotherapy regimen (regime/therapy)

Regime/therapy

58571000210109

Breast metastatic pamidronate chemotherapy regimen (regime/therapy)

Regime/therapy

58551000210101

Breast metastatic pembrolizumab every three weeks flat dosing (regime/therapy)

Regime/therapy

58461000210102

Breast metastatic trastuzumab every three weeks and vinorelbine intravenous chemotherapy regimen (regime/therapy)

Regime/therapy

58471000210108

Breast metastatic trastuzumab every three weeks and vinorelbine oral chemotherapy regimen (regime/therapy)

Regime/therapy

58651000210102

Breast metastatic trastuzumab every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

57831000210108

Breast metastatic trastuzumab subcutaneous chemotherapy regimen (regime/therapy)

Regime/therapy

57821000210106

Breast metastatic vinorelbine intravenous chemotherapy regimen (regime/therapy)

Regime/therapy

57771000210101

Breast metastatic vinorelbine intravenous weekly chemotherapy regimen (regime/therapy)

Regime/therapy

57761000210107

Breast non-metastatic AC doxorubicin and cyclophosphamide dose dense chemotherapy regimen (regime/therapy)

Regime/therapy

57841000210100

Breast non-metastatic doxorubicin and cyclophosphamide every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

57851000210102

Breast non-metastatic paclitaxel weekly pertuzumab and trastuzumab every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

52791000210100

Colorectal rectal metastatic capecitabine chemoradiation continuous dosing chemotherapy regimen (regime/therapy)

Regime/therapy

131531000210109

Growth factor prophylaxis not recommended (situation)

Regime/therapy

52691000210106

Respiratory mesothelioma metastatic carboplatin and pemetrexed chemotherapy regimen (regime/therapy)

Regime/therapy

52711000210108

Respiratory mesothelioma metastatic cisplatin and pemetrexed chemotherapy regimen (regime/therapy)

Regime/therapy

52831000210106

Respiratory non small cell lung cancer metastatic carboplatin and docetaxel chemotherapy regimen (regime/therapy)

Regime/therapy

52821000210109

Respiratory non small cell lung cancer metastatic carboplatin and pemetrexed chemotherapy regimen (regime/therapy)

Regime/therapy

52811000210104

Respiratory non small cell lung cancer metastatic docetaxel every three weeks chemotherapy regimen (regime/therapy)

Regime/therapy

52801000210101

Respiratory non small cell lung cancer metastatic docetaxel weekly (regime/therapy)

Regime/therapy

52681000210109

Respiratory non small cell lung cancer metastatic paclitaxel weekly (regime/therapy)

Regime/therapy

52721000210103

Respiratory non small cell lung cancer metastic afatinib chemotherapy regimen (regime/therapy)

Regime/therapy

52731000210101

Respiratory non small cell lung cancer metastic atezolizumab chemotherapy regimen (regime/therapy)

Regime/therapy

52741000210109

Respiratory non small cell lung cancer metastic dabrafenib and trametinib chemotherapy regimen (regime/therapy)

Regime/therapy

52701000210106

Respiratory non small cell lung cancer metastic nivolumab biweekly chemotherapy regimen (regime/therapy)

Regime/therapy

52751000210107

Respiratory non small cell lung cancer metastic nivolumab biweekly weight base dosing chemotherapy regimen (regime/therapy)

Regime/therapy

52761000210105

Respiratory non small cell lung cancer metastic nivolumab every four weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

52851000210100

Respiratory non small cell lung cancer non-metastatic cisplatin and etoposide chemoradiation chemotherapy regimen (regime/therapy)

Regime/therapy

52861000210102

Respiratory non small cell lung cancer non-metastatic crizotinib chemotherapy regimen (regime/therapy)

Regime/therapy

52781000210102

Respiratory non small cell lung cancer non-metastatic durvalumab chemotherapy regimen (regime/therapy)

Regime/therapy

52841000210103

Respiratory non small cell lung cancer non-metastatic superior sulcus pancoast cisplatin and etoposide chemoradiation chemotherapy regimen (regime/therapy)

Regime/therapy

52771000210104

Respiratory non small cell lung cancer non-metastic atezolizumab chemotherapy regimen (regime/therapy)

Regime/therapy

57371000210102

Respiratory small cell lung cancer metastatic CAV extensive cyclophoshamide 750, doxorubicin and vincristine chemotherapy regimen (regime/therapy)

Regime/therapy

52871000210108

Respiratory small cell lung cancer metastatic CAV extensive cyclophosphamide 1000, doxorubicin and vincristine chemotherapy regimen (regime/therapy)

Regime/therapy

57381000210100

Respiratory small cell lung cancer non-metastatic Limited carboplatin and etoposide chemotherapy regimen (regime/therapy)

Regime/therapy

57391000210103

Respiratory small cell lung cancer non-metastatic Limited cisplatin and etoposide chemotherapy regimen (regime/therapy)

Regime/therapy

57441000210102

Skin cancer basal cell metastatic vismodegib chemotherapy regimen (regime/therapy)

Regime/therapy

57461000210101

Skin cancer melanoma metastatic - cobimetinib and vemurafenib chemotherapy regimen (regime/therapy)

Regime/therapy

57471000210107

Skin cancer melanoma metastatic - dacarbazine chemotherapy regimen (regime/therapy)

Regime/therapy

57481000210109

Skin cancer melanoma metastatic - imatinib chemotherapy regimen (regime/therapy)

Regime/therapy

57491000210106

Skin cancer melanoma metastatic - ipilimumab 1mg/kg and nivolumab 3mg/kg chemotherapy regimen (regime/therapy)

Regime/therapy

57501000210101

Skin cancer melanoma metastatic - ipilimumab 3mg/kg and nivolumab 1mg/kg chemotherapy regimen (regime/therapy)

Regime/therapy

57511000210104

Skin cancer melanoma metastatic - ipilimumab and pembrolizumab chemotherapy regimen (regime/therapy)

Regime/therapy

57541000210103

Skin cancer melanoma metastatic - nivolumab every four weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57521000210109

Skin cancer melanoma metastatic - nivolumab every two weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57531000210106

Skin cancer melanoma metastatic - nivolumab every two weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57571000210108

Skin cancer melanoma metastatic - pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57551000210100

Skin cancer melanoma metastatic - pembrolizumab every three weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57561000210102

Skin cancer melanoma metastatic - pembrolizumab every three weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57401000210100

Skin cancer melanoma metastatic binimetinib and encorafenib chemotherapy regimen (regime/therapy)

Regime/therapy

57451000210104

Skin cancer melanoma metastatic carboplatin, paclitaxel, and bevacizumab chemotherapy regimen (regime/therapy)

Regime/therapy

57581000210105

Skin cancer melanoma non-metastatic - nivolumab every two weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57591000210107

Skin cancer melanoma non-metastatic - nivolumab every two weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57611000210100

Skin cancer melanoma non-metastatic - pembrolizumab every three weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57621000210105

Skin cancer melanoma non-metastatic - pembrolizumab every three weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57601000210102

Skin cancer melanoma non-metastatic nivolumab every four weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57631000210107

Skin cancer melanoma non-metastatic pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57411000210103

Skin cancer merkel cell metastatic pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57431000210105

Skin cancer Merkel cell metastatic pembrolizumab every three weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57421000210108

Skin cancer Merkel cell metastatic pembrolizumab every three weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57641000210104

Skin cancer squamous cell metastatic - pembrolizumab every three weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57651000210101

Skin cancer squamous cell metastatic - pembrolizumab every three weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57661000210103

Skin cancer squamous cell metastatic pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy)

Regime/therapy

54231000210103

Upper gastrointestinal biliary and gallbladder Metastatic carboplatin and gemcitabine chemotherapy regimen (regime/therapy)

Regime/therapy

54221000210100

Upper gastrointestinal biliary and gallbladder metastatic gemcitabine chemotherapy regimen (regime/therapy)

Regime/therapy

54151000210104

Upper gastrointestinal biliary and gallbladder metastatic modified fluorouracil, folinic acid and oxaliplatin high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

54211000210105

Upper gastrointestinal biliary and gallbladder metastatic modified fluorouracil, folinic acid and oxaliplatin low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

54191000210106

Upper gastrointestinal biliary and gallbladder non-metastatic capecitabine chemotherapy regimen (regime/therapy)

Regime/therapy

54181000210109

Upper gastrointestinal biliary and gallbladder non-metastatic modified fluorouracil, folinic acid and oxaliplatin low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

57281000210108

Upper gastrointestinal biliary and gallbladder non-netastatic - modified fluorouracil, folinic acid and oxaliplatin high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

54061000210102

Upper gastrointestinal gastric and oesophageal metastatic - modified fluorouracil, folinic acid and irinotecan low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

54081000210105

Upper gastrointestinal gastric and oesophageal metastatic - modified fluorouracil, folinic acid and oxaliplatin high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

53971000210106

Upper gastrointestinal gastric and oesophageal metastatic - modified oxaliplatin, folinic acid and fluorouracil low dose folinic acid and trastuzumab chemotherapy regimen (regime/therapy)

Regime/therapy

53061000210104

Upper gastrointestinal gastric and oesophageal metastatic capecitabine and oxaliplatin chemotherapy regimen (regime/therapy)

Regime/therapy

52941000210106

Upper gastrointestinal gastric and oesophageal metastatic capecitabine, oxaliplatin and trastuzumab chemotherapy regimen (regime/therapy)

Regime/therapy

54121000210108

Upper gastrointestinal gastric and oesophageal metastatic cisplatin and capecitabine chemotherapy regimen (regime/therapy)

Regime/therapy

54251000210109

Upper gastrointestinal gastric and oesophageal metastatic cisplatin and fluorouracil chemotherapy regimen (regime/therapy)

Regime/therapy

57291000210105

Upper gastrointestinal gastric and oesophageal metastatic cisplatin, capecitabine and trastuzumab chemotherapy regimen (regime/therapy)

Regime/therapy

57301000210109

Upper gastrointestinal gastric and oesophageal metastatic cisplatin, fluorouracil and trastuzumab chemotherapy regimen (regime/therapy)

Regime/therapy

52921000210100

Upper gastrointestinal gastric and oesophageal metastatic irinotecan every two weeks chemotherapy regimen (regime/therapy)

Regime/therapy

52951000210109

Upper gastrointestinal gastric and oesophageal metastatic modified fluorouracil, folinic acid and oxaliplatin high dose folinic acid and trastuzumab chemotherapy regimen (regime/therapy)

Regime/therapy

53071000210105

Upper gastrointestinal gastric and oesophageal metastatic modified fluorouracil, folinic acid, irinotecan high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

52891000210107

Upper gastrointestinal gastric and oesophageal metastatic modified fluorouracil, folinic acid, oxaliplatin low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

54091000210107

Upper gastrointestinal gastric and oesophageal metastatic paclitaxel and ramucirumab chemotherapy regimen (regime/therapy)

Regime/therapy

52911000210105

Upper gastrointestinal gastric and oesophageal metastatic paclitaxel weekly 3/1 dosing chemotherapy regimen (regime/therapy)

Regime/therapy

52901000210108

Upper gastrointestinal gastric and oesophageal metastatic paclitaxel weekly chemotherapy regimen (regime/therapy)

Regime/therapy

52971000210101

Upper gastrointestinal gastric and oesophageal metastatic pembrolizumab every three weeks flat dose chemotherapy regimen (regime/therapy)

Regime/therapy

54111000210103

Upper gastrointestinal gastric and oesophageal metastatic pembrolizumab every three weeks weight based dosing chemotherapy regimen (regime/therapy)

Regime/therapy

54101000210100

Upper gastrointestinal gastric and oesophageal metastatic ramucirumab chemotherapy regimen (regime/therapy)

Regime/therapy

54201000210108

Upper gastrointestinal gastric and oesophageal metastatic trifluridine and tipiracil chemotherapy regimen (regime/therapy)

Regime/therapy

53031000210108

Upper gastrointestinal gastric and oesophageal non-metastatic docetaxel, oxaliplatin, folinic acid and fluorouracil high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

53051000210102

Upper gastrointestinal gastric and oesophageal non-metastatic docetaxel, oxaliplatin, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

52931000210103

Upper gastrointestinal gastric and oesophageal non-metastatic modified fluorouracil, folinic acid and oxaliplatin chemoradiation high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

52981000210104

Upper gastrointestinal gastric and oesophageal non-metastic modified fluorouracil, folinic acid and oxaliplatin chemoradiation low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

57311000210106

Upper gastrointestinal gastric metastatic cisplatin, capecitabine and pembrolizumab flat dose chemotherapy regimen (regime/therapy)

Regime/therapy

52961000210107

Upper gastrointestinal gastric non-metastatic capecitabine and oxaliplatin chemotherapy regimen (regime/therapy)

Regime/therapy

54071000210108

Upper gastrointestinal gastric non-metastatic fluorouracil chemoradiation modified MacDonald chemotherapy regimen (regime/therapy)

Regime/therapy

53041000210100

Upper gastrointestinal gastrointestinal stroma cell tumours metastatic imatinib chemotherapy regimen (regime/therapy)

Regime/therapy

52991000210102

Upper gastrointestinal gastrointestinal stromal cell tumors metastatic regorafenib chemotherapy regimen (regime/therapy)

Regime/therapy

54161000210101

Upper gastrointestinal gastrointestinal stromal cell tumour metastatic sunitinib 2/1 dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57321000210101

Upper gastrointestinal gastrointestinal stromal cell tumours metastatic sunitinib 4/2 dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57331000210104

Upper gastrointestinal gastrointestinal stromal cell tumours non-metastatic imatinib chemotherapy regimen (regime/therapy)

Regime/therapy

57351000210105

Upper gastrointestinal hepatic metastatic atezolizumab and bevacizumab chemotherapy regimen (regime/therapy)

Regime/therapy

57341000210107

Upper gastrointestinal hepatic metastatic atezolizumab chemotherapy regimen (regime/therapy)

Regime/therapy

57361000210108

Upper gastrointestinal hepatic metastatic lenvatinib chemotherapy regimen (regime/therapy)

Regime/therapy

54131000210105

Upper gastrointestinal hepatic metastatic sorafenib chemotherapy regimen (regime/therapy)

Regime/therapy

52881000210105

Upper gastrointestinal oesophageal non-metastatic carboplatin and paclitaxel weekly chemoradiation chemotherapy regimen (regime/therapy)

Regime/therapy

54241000210106

Upper gastrointestinal oesophageal non-metastatic cisplatin and fluorouracil chemoradiation chemotherapy regimen (regime/therapy)

Regime/therapy

53001000210103

Upper gastrointestinal oesophageal non-metastatic cisplatin and fluorouracil chemoradiation Herskovic chemotherapy regimen (regime/therapy)

Regime/therapy

53011000210101

Upper gastrointestinal oesophageal non-metastatic mitomycin and fluorouracil chemoradiation chemotherapy regimen (regime/therapy)

Regime/therapy

53021000210106

Upper gastrointestinal oesophageal non-metastatic mitomycin and fluorouracil chemoradiation MSKCC chemotherapy regimen (regime/therapy)

Regime/therapy

57721000210100

Upper gastrointestinal pancreas metastatic docetaxel, gemcitabine, cisplatin and capecitabine chemotherapy regimen (regime/therapy)

Regime/therapy

54171000210107

Upper gastrointestinal pancreas metastatic gemcitabine chemotherapy regimen (regime/therapy)

Regime/therapy

57261000210100

Upper gastrointestinal pancreas metastatic modified fluorouracil, folinic acid and oxaliplatin high dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

57271000210106

Upper gastrointestinal pancreas metastatic modified fluorouracil, folinic acid and oxaliplatin low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

57701000210108

Upper gastrointestinal pancreas metastatic olaparib chemotherapy regimen (regime/therapy)

Regime/therapy

57741000210106

Upper gastrointestinal pancreas non-metastatic capecitabine and gemcitabine adjuvant chemotherapy regimen (regime/therapy)

Regime/therapy

57751000210109

Upper gastrointestinal pancreas non-metastatic capecitabine and gemcitabine advanced chemotherapy regimen (regime/therapy)

Regime/therapy

57671000210109

Upper gastrointestinal pancreas non-metastatic capecitabine chemoradiation 5 day dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57681000210106

Upper gastrointestinal Pancreas non-metastatic capecitabine chemoradiation continuous dosing chemotherapy regimen (regime/therapy)

Regime/therapy

57711000210105

Upper gastrointestinal pancreas non-metastatic gemcitabine adjuvant chemotherapy regimen (regime/therapy)

Regime/therapy

57691000210108

Upper gastrointestinal pancreas non-metastatic gemcitabine advanced chemotherapy regimen (regime/therapy)

Regime/therapy

57731000210103

Upper gastrointestinal pancreas non-metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy)

Regime/therapy

91721000210101

Augmentation of labor not performed (situation)

Situation

111511000210108

Fetal anomaly screening declined (situation)

Situation

91491000210107

History of admission to neonatal intensive care unit (situation)

Situation

91501000210102

History of admission to special care baby unit (situation)

Situation

111501000210106

History of cervical intraepithelial neoplasia grade 3 (situation)

Situation

91701000210109

History of cervical smear performed for more than three years (situation)

Situation

121501000210102

History of cervical smear performed within last 12 months (situation)

Situation

91691000210109

History of cervical smear performed within last three years (situation)

Situation

91681000210107

History of cervical smear performed within last two years (situation)

Situation

101681000210103

History of complementary therapy (situation)

Situation

91461000210102

History of complication in pregnancy (situation)

Situation

91621000210106

History of first trimester miscarriage (situation)

Situation

91531000210107

History of genital herpes simplex (situation)

Situation

91521000210105

History of genital warts (situation)

Situation

101651000210108

History of human immunodeficiency virus infection (situation)

Situation

101591000210102

History of non-opioid analgesic therapy (situation)

Situation

111491000210101

History of non-pharmacological pain management therapy (situation)

Situation

101611000210109

History of previous baby artificially fed (situation)

Situation

91711000210106

History of previous baby exclusively breastfed (situation)

Situation

101471000210102

History of previous baby fully breastfed (situation)

Situation

121491000210107

History of previous baby partially breast fed (situation)

Situation

101671000210100

History of previous baby under pediatric care while in maternity unit (situation)

Situation

131501000210104

History of regional anesthesia (situation)

Situation

101521000210100

Newborn hearing screening not done (situation)

Situation

101571000210101

No history of administration of analgesic (situation)

Situation

91471000210108

No history of neonatal care admission (situation)

Situation

91731000210104

Primary facility birth planned (situation)

Situation

91741000210107

Secondary facility birth planned (situation)

Situation

91751000210105

Tertiary facility birth planned (situation)

Situation

101631000210102Vaccine product against Severe acute respiratory syndrome coronavirus 2 given (situation)Situation


Table 3.1 Reference sets in the SNOMED NZ Extension April 2022 release

SNOMED CT Concept ID

(SCTID)

SNOMED CT Fully Specified Name (FSN)

Members

351000210106

New Zealand adverse reaction manifestation reference set (foundation metadata concept)

1886

72671000210109New Zealand alcohol consumption reference set (foundation metadata concept)3

421000210109

New Zealand ambulance clinical impression reference set (foundation metadata concept)

176

61241000210100New Zealand biological substance common allergen reference set (foundation metadata concept)208

91000210107

New Zealand cardiology reference set (foundation metadata concept)

63

61251000210102New Zealand chemical substance common allergen reference set (foundation metadata concept)623

191000210102

New Zealand child developmental services reference set (foundation metadata concept)

137

241000210102

New Zealand child health assessment reference set (foundation metadata concept)

186

471000210108

New Zealand clinical specialty reference set (foundation metadata concept)

158

61271000210105New Zealand common pharmaceutical dose form reference set12
61281000210107New Zealand common pharmaceutical dose frequency reference set12
61291000210109New Zealand common pharmaceutical dose unit reference set11
61231000210108New Zealand COVID-19 adverse event from immunization reference set58

261000210101

New Zealand disability reference set (foundation metadata concept)

96

61261000210104New Zealand edible substance common allergen reference set420

61000210102

New Zealand emergency care diagnosis reference set (foundation metadata concept)

1451

71000210108

New Zealand emergency care presenting complaint reference set (foundation metadata concept)

160

321000210102

New Zealand emergency care procedure reference set (foundation metadata concept)

73

141000210106

New Zealand endocrinology reference set (foundation metadata concept)

263

181000210104

New Zealand general paediatric reference set (foundation metadata concept)

441

131000210103

New Zealand general surgery reference set (foundation metadata concept)

97

101000210108

New Zealand gynaecology reference set (foundation metadata concept)

143

451000210100

New Zealand health occupation reference set (foundation metadata concept)

86

461000210102

New Zealand health service type reference set (foundation metadata concept)

112

501000210102

New Zealand laboratory order reference set (foundation metadata concept)

956

72621000210105New Zealand maternity Apgar score reference set (foundation metadata concept)33
72631000210107New Zealand maternity complementary therapies reference set (foundation metadata concept)17

72601000210102

New Zealand maternity complications reference set (foundation metadata concept)

32

72611000210100

New Zealand maternity disorders reference set (foundation metadata concept)

44

72661000210103

New Zealand maternity family history reference set (foundation metadata concept)

12

72591000210107

New Zealand maternity findings reference set (foundation metadata concept)

156

72581000210105

New Zealand maternity mode of delivery reference set (foundation metadata concept)

4

72571000210108

New Zealand maternity outcomes reference set (foundation metadata concept)

8

72541000210103

New Zealand maternity previous complications reference set (foundation metadata concept)

47

72551000210100

New Zealand maternity previous disorders reference set (foundation metadata concept)

63

72531000210106

New Zealand maternity previous findings reference set (foundation metadata concept)

49

72521000210109

New Zealand maternity previous mode of delivery reference set (foundation metadata concept)

4

72511000210104

New Zealand maternity previous outcomes reference set (foundation metadata concept)

9

72501000210101

New Zealand maternity previous procedures reference set (foundation metadata concept)

23

72561000210102

New Zealand maternity procedures reference set (foundation metadata concept)

51

72641000210104

New Zealand maternity screening and tests reference set (foundation metadata concept)

21

72651000210101

New Zealand maternity substances reference set (foundation metadata concept)

13

391000210104

New Zealand microorganism reference set (foundation metadata concept)

18718

50931000210104New Zealand nephrology reference set (foundation metadata)99

72691000210108

New Zealand non-medicinal drug reference set (foundation metadata concept)

16

72681000210106

New Zealand non-medicinal drug use reference set (foundation metadata concept)

6

251000210104

New Zealand notifiable disease reference set (foundation metadata concept)

96

50941000210107New Zealand ophthalmology reference set (foundation metadata concept)64
121531000210107

New Zealand radiology procedures reference set (foundation metadata concept)

915

121000210100

New Zealand rheumatology reference set (foundation metadata concept)

126

121521000210105New Zealand severe acute respiratory syndrome coronavirus 2 symptoms reference set (foundation metadata concept)19

481000210105

New Zealand site of care reference set (foundation metadata concept)

8

72731000210103New Zealand smoking intervention reference set (foundation metadata concept)5

51000210100

New Zealand smoking reference set (foundation metadata concept)

42

72741000210106New Zealand smoking status reference set (foundation metadata concept)4

441000210103

New Zealand surgical complication reference set (foundation metadata concept)

147

72721000210100New Zealand vaping status reference set (foundation metadata concept)7



Approvals


Final Version

Date

Approver

Comments

0.1


Terance Shird


0.2

Lea MiharsaApproved
1.0

Alastair KenworthyApproved



Download .pdf here:






Draft Amendment History


Version

Date

Editor

Comments

0.1

 

Andrew AtkinsonInitial draft created
0.2

Lea MiharsaFinal draft
1.0

 

Alastair KenworthyFinal draft updated
  • No labels